Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Harrow Health, Inc. Harrow Health, Inc. Changes Corporate Name to Harrow, Inc. September 29, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Announces Second Quarter 2023 Financial Results August 09, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Launches VIGAMOX® in the U.S. July 31, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow to Announce Second Quarter 2023 Financial Results on August 9, 2023 July 26, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Prices $60 Million Public Offering of Common Stock July 19, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Acquires Santen’s Branded Ophthalmic Portfolio July 18, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance July 18, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Announces Proposed Public Offering of Common Stock July 18, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq July 18, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Announces First Quarter 2023 Financial Results May 11, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Announces Availability of Fortisite™ Formulations for In-Office Use January 05, 2023 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Secures Capital to Close Recently Announced Acquisition December 16, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Announces Proposed Offering of $100 Million of Senior Notes Due 2027 and “BB” Rating from Egan-Jones December 14, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health to Participate in H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference August 11, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health Announces Second Quarter 2022 Financial Results August 09, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health to Announce Second Quarter 2022 Financial Results on August 9, 2022 July 27, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health Announces Launch of IOPIDINE® 1% and MAXITROL® in the United States June 24, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health Announces First Quarter 2022 Financial Results May 05, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health to Participate in B. Riley Securities’ Annual Neuro & Ophthalmology Investor Conference April 22, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health to Announce First Quarter 2022 Financial Results on May 5, 2022 April 20, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health Announces Appointments to Its Board of Directors March 31, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health to Announce Fourth Quarter and Year-End 2021 Financial Results on March 10, 2022 February 24, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health Announces FDA Acceptance of New Drug Application for AMP-100 February 22, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health to Present at Aegis Virtual Conference February 15, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health Publishes Corporate Transparency Report February 08, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health to Participate in H.C. Wainwright BioConnect Conference January 10, 2022 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops December 20, 2021 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health Added to the Nasdaq Biotechnology Index December 13, 2021 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health Announces Third Quarter 2021 Financial Results November 09, 2021 From Harrow Health, Inc. Via Business Wire Tickers HROW Harrow Health to Announce Third Quarter 2021 Financial Results on November 9, 2021 October 25, 2021 From Harrow Health, Inc. Via Business Wire Tickers HROW Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.